Supernus Pharmaceuticals (SUPN) Finished Goods (2013 - 2026)
Supernus Pharmaceuticals (SUPN) posted Finished Goods of $33.8 million for Q2 2026, up 69.4% from $19.95 million a year earlier and up 73.0% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Finished Goods (2013 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals' Finished Goods came in at $21.12 million, up 28.4% from FY2024.
- Annual Finished Goods shows a five-year compound annual growth rate of 4.3% (FY2020 to FY2025).
- In prior years, Supernus Pharmaceuticals' Finished Goods was $16.44 million in FY2024 (-45.1%), $29.92 million in FY2023 (-14.5%), $35.01 million in FY2022 (+6.3%) and $32.92 million in FY2021 (+92.2%).
- The Q2 2026 figure stands as the highest quarterly Finished Goods since Q3 2023.
- On a year-over-year basis, Finished Goods increased in two of the last eight quarters, with an average decline of 10.5%.
- The strongest year-over-year quarter for Finished Goods in the past five years was Q3 2022, with growth of 272.5%; the weakest was Q4 2024, with a decline of 45.1%.
- According to Business Quant data, Finished Goods for the three prior quarters was $19.54 million (Q1 2026), $21.12 million (Q4 2025) and $16.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.80 Mn |
| Mar 31, 2026 | 19.54 Mn |
| Dec 31, 2025 | 21.12 Mn |
| Sep 30, 2025 | 16.71 Mn |
| Jun 30, 2025 | 19.95 Mn |
| Mar 31, 2025 | 22.07 Mn |
| Dec 31, 2024 | 16.44 Mn |
| Sep 30, 2024 | 24.31 Mn |
| Jun 30, 2024 | 28.67 Mn |
| Mar 31, 2024 | 33.03 Mn |
| Dec 31, 2023 | 29.92 Mn |
| Sep 30, 2023 | 34.96 Mn |
| Jun 30, 2023 | 38.81 Mn |
| Mar 31, 2023 | 34.26 Mn |
| Dec 31, 2022 | 35.01 Mn |
| Sep 30, 2022 | 46.69 Mn |
| Jun 30, 2022 | 40.54 Mn |
| Mar 31, 2022 | 33.34 Mn |
| Dec 31, 2021 | 32.92 Mn |
| Sep 30, 2021 | 12.54 Mn |
API Access
Supernus Pharmaceuticals Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();